FDA Finds Lead in 400 Lipsticks
Here's a startling, but perhaps not surprising, bit of news for those inclined to put colors on their kissers: The Food and Drug Administration ran some tests on hundreds of lipsticks and found that many made by popular brands such as L'Oreal, Cover Girl and Nars contained a very unsexy ingredient: lead.
Here’s a startling, but perhaps not surprising, bit of news for those inclined to put colors on their kissers: The Food and Drug Administration ran some tests on hundreds of lipsticks and found that many made by popular brands such as L’Oreal, Cover Girl and Nars contained a very unsexy ingredient: lead. –KA
Your support matters…The Washington Post:
Four hundred of the nation’s most popular lipsticks contained trace levels of lead when tested recently by the federal government, confirming similar results of earlier analyses but on a much wider scale and at higher levels than previously detected.
The findings exacerbate an ongoing disagreement between the FDA and the Campaign for Safe Cosmetics, a consumer group that’s been pushing the government for years to set limits for lead levels in lipsticks. The FDA has resisted, insisting that the lead levels detected in two rounds of its own testing, including the most recent one, do not pose safety risks. But the consumer group says the FDA has no scientific basis for its conclusion.
Independent journalism is under threat and overshadowed by heavily funded mainstream media.
You can help level the playing field. Become a member.
Your tax-deductible contribution keeps us digging beneath the headlines to give you thought-provoking, investigative reporting and analysis that unearths what's really happening- without compromise.
Give today to support our courageous, independent journalists.
Editorial Cartoons
Women
A pharmacist and public health expert explain this new era in contraception.
Technology
Elon Musk's company has been hyping up human trials for years but only after a myriad of scandals around animal testing.
TD Original
In previously unreported statements made at the 2017 International Drug Policy Reform Conference, Rick Doblin, executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS), discussed rumors of secret Pentagon studies with MDMA, as well as the reasons for hesitancy on the part of some government agencies to fund MAPS’ research.
The FDA’s strict guidance on test confirmations is one of several obstacles that has slowed the federal government’s response to COVID-19. The FDA could change its rules to speed things up, but hasn’t.
The agency's OK, four months after it rejected the drug over safety concerns, may stoke questions about standards for clearing medications.
You need to be a supporter to comment.
There are currently no responses to this article.
Be the first to respond.